Co-Diagnostics, Inc. Inventory Write-down
Co-Diagnostics, Inc. (CODX) reported Inventory Write-down of -$59.22 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:InventoryWriteDown · last filed 2026-08-13
- Co-Diagnostics, Inc. inventory write-down for the quarter ending 2026-06-30 was -$31.33K.
- Co-Diagnostics, Inc. inventory write-down for the quarter ending 2026-03-31 was -$27.88K.
- Co-Diagnostics, Inc. inventory write-down for the quarter ending 2025-12-31 was $88.04K, a 45.51% decline year-over-year.
- Co-Diagnostics, Inc. inventory write-down for the quarter ending 2025-09-30 was -$43.68K, a 154.25% decline year-over-year.
- Co-Diagnostics, Inc. inventory write-down for fiscal 2025 was -$50.94K, a 115.60% decline from fiscal 2024.
- Co-Diagnostics, Inc. inventory write-down for fiscal 2024 was $326.51K, a 89.90% decline from fiscal 2023.
- Co-Diagnostics, Inc. inventory write-down for fiscal 2023 was $3.23M, a 2083.19% increase from fiscal 2022.
- Co-Diagnostics, Inc. inventory write-down for fiscal 2022 was $148.10K.
| Period end | Inventory Write-down 3 month | Inventory Write-down 6 month | Inventory Write-down 9 month | Inventory Write-down 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$31.33K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | -$59.22K 10-Q · filed 2026-08-13 | $28.82K derived: sum of 3 quarters · filed 2026-08-13 | -$14.86K derived: sum of 4 quarters · filed 2026-08-13 |
| 2026-03-31 | -$27.88K 10-Q · filed 2026-05-14 | $60.16K derived: sum of 2 quarters · filed 2026-05-14 | $16.47K derived: sum of 3 quarters · filed 2026-05-14 | -$41.51K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-12-31 | $88.04K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $44.36K derived: sum of 2 quarters · filed 2026-03-31 | -$13.62K derived: sum of 3 quarters · filed 2026-08-13 | -$50.94K 10-K · filed 2026-03-31 |
| 2025-09-30 | -$43.68K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | -$101.66K derived: sum of 2 quarters · filed 2026-08-13 | -$138.98K 10-Q · filed 2025-11-13 | $22.57K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-06-30 | -$57.98K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | -$95.30K 10-Q · filed 2026-08-13 | $66.25K derived: sum of 3 quarters · filed 2026-08-13 | $146.78K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-03-31 | -$37.32K 10-Q · filed 2026-05-14 | $124.24K derived: sum of 2 quarters · filed 2026-05-14 | $204.76K derived: sum of 3 quarters · filed 2026-05-14 | $240.49K derived: sum of 4 quarters · filed 2026-05-14 |
| 2024-12-31 | $161.56K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $242.08K derived: sum of 2 quarters · filed 2026-03-31 | $277.81K derived: sum of 3 quarters · filed 2026-03-31 | $326.51K 10-K · filed 2026-03-31 |
| 2024-09-30 | $80.53K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $116.25K derived: sum of 2 quarters · filed 2025-11-13 | $164.96K 10-Q · filed 2025-11-13 | $2.90M derived: sum of 4 quarters · filed 2025-11-13 |
| 2024-06-30 | $35.73K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | $84.43K 10-Q · filed 2025-08-14 | $2.82M derived: sum of 3 quarters · filed 2025-08-14 | $2.88M derived: sum of 4 quarters · filed 2025-08-14 |
| 2024-03-31 | $48.70K 10-Q · filed 2025-05-08 | $2.79M derived: sum of 2 quarters · filed 2025-05-08 | $2.84M derived: sum of 3 quarters · filed 2025-05-08 | $3.08M derived: sum of 4 quarters · filed 2025-05-08 |
| 2023-12-31 | $2.74M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27 | $2.79M derived: sum of 2 quarters · filed 2025-03-27 | $3.03M derived: sum of 3 quarters · filed 2025-03-27 | $3.23M 10-K · filed 2025-03-27 |
| 2023-09-30 | $53.12K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $293.71K derived: sum of 2 quarters · filed 2024-11-07 | $493.82K 10-Q · filed 2024-11-07 | |
| 2023-06-30 | $240.59K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $440.70K 10-Q · filed 2024-08-08 | ||
| 2023-03-31 | $200.11K 10-Q · filed 2024-05-09 | |||
| 2022-12-31 | $148.10K 10-K · filed 2024-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| ALLURION TECHNOLOGIES, INC. (ALUR) | United States | $0.010B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Picard Medical, Inc. (PMI) | United States | $0.011B | -0.01 |